BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30639375)

  • 1. Rev-erbα activation down-regulates hepatic Pck1 enzyme to lower plasma glucose in mice.
    Yuan X; Dong D; Li Z; Wu B
    Pharmacol Res; 2019 Mar; 141():310-318. PubMed ID: 30639375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E4bp4 regulates carboxylesterase 2 enzymes through repression of the nuclear receptor Rev-erbα in mice.
    Zhao M; Zhang T; Yu F; Guo L; Wu B
    Biochem Pharmacol; 2018 Jun; 152():293-301. PubMed ID: 29653076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nuclear receptor Rev-erbα participates in circadian regulation of Ugt2b enzymes in mice.
    Zhang T; Guo L; Yu F; Chen M; Wu B
    Biochem Pharmacol; 2019 Mar; 161():89-97. PubMed ID: 30639455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy.
    Shen W; Zhang W; Ye W; Wang H; Zhang Q; Shen J; Hong Q; Li X; Wen G; Wei T; Zhang J
    Theranostics; 2020; 10(10):4466-4480. PubMed ID: 32292508
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological activation of REV-ERBα represses LPS-induced microglial activation through the NF-κB pathway.
    Guo DK; Zhu Y; Sun HY; Xu XY; Zhang S; Hao ZB; Wang GH; Mu CC; Ren HG
    Acta Pharmacol Sin; 2019 Jan; 40(1):26-34. PubMed ID: 29950615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rev-erb agonist and TGF-β similarly affect autophagy but differentially regulate hepatic stellate cell fibrogenic phenotype.
    Thomes PG; Brandon-Warner E; Li T; Donohue TM; Schrum LW
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):137-147. PubMed ID: 27840152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
    Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian Clock Component Rev-erb
    Xu H; Chen M; Yu F; Zhang T; Wu B
    Drug Metab Dispos; 2020 Aug; 48(8):681-689. PubMed ID: 32527940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of Rev-Erbα in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbα have anti-inflammatory and neuroprotective effects in the pilocarpine model.
    Yue J; He J; Wei Y; Shen K; Wu K; Yang X; Liu S; Zhang C; Yang H
    J Neuroinflammation; 2020 Jan; 17(1):43. PubMed ID: 32005256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II Suppresses Rev-erbα Expression in THP-1 Macrophages via the Ang II Type 1 Receptor/Liver X Receptor α Pathway.
    Wang S; Gu X; Zhang Q; Zhang X; Li Y; Yao Y; Yu B; Zhang Y
    Cell Physiol Biochem; 2018; 46(1):303-313. PubMed ID: 29590657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
    Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
    FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REV-ERBα Agonist SR9009 Promotes a Negative Energy Balance in Goldfish.
    Saiz N; Herrera-Castillo L; Isorna E; Delgado MJ; Conde-Sieira M; Soengas JL; de Pedro N
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeability.
    Ni Y; Zhao Y; Ma L; Wang Z; Ni L; Hu L; Fu Z
    Metabolism; 2021 Jan; 114():154409. PubMed ID: 33096076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
    Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
    Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REV-ERB
    Zhang T; Zhao M; Lu D; Wang S; Yu F; Guo L; Wen S; Wu B
    Drug Metab Dispos; 2018 Mar; 46(3):248-258. PubMed ID: 29237721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
    Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM
    Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
    Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
    Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deleted in breast cancer 1 (DBC1) protein regulates hepatic gluconeogenesis.
    Nin V; Chini CC; Escande C; Capellini V; Chini EN
    J Biol Chem; 2014 Feb; 289(9):5518-27. PubMed ID: 24415752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome.
    Hong H; Cheung YM; Cao X; Wu Y; Li C; Tian XY
    Biochem Pharmacol; 2021 Oct; 192():114701. PubMed ID: 34324866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rev-erbα regulates hepatic ischemia-reperfusion injury in mice.
    Lin Y; Lin L; Gao L; Wang S; Wu B
    Biochem Biophys Res Commun; 2020 Sep; 529(4):916-921. PubMed ID: 32819599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.